Suchergebnisse - "Rimel, Bobbie J"

PubPharm (30)

1

NRG-GY012 : Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer

enthalten in: Cancer | 2024

von Rimel, B. | Enserro, D. | Bender, D. | +10

2

Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting

enthalten in: Gynecologic oncology reports | 2024

von Rimel, B. | Chase, D. | Perhanidis, J. | +9

3

Sexual orientation and gender identity inequities in cervical cancer screening by race and ethnicity

enthalten in: Cancer causes & control : CCC | 2024

von Lin, E. | Sleboda, P. | Rimel, B. | +3

4

Inequities in colorectal and breast cancer screening : At the intersection of race/ethnicity, sexuality, and gender

enthalten in: SSM - population health | 2023

von Lin, E. | Sleboda, P. | Rimel, B. | +1

5

Tyrosine kinase inhibitor toxicities : A society of gynecologic oncology review and recommendations

enthalten in: Gynecologic oncology | 2023

von Rimel, B. | Crane, E. | Hou, J. | +5

6

Current gaps and opportunities in screening, prevention, and treatment of cervical cancer

enthalten in: Cancer | 2022

von Rimel, B. | Kunos, C. | Macioce, N. | +1

7

Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study : Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects

enthalten in: Cancer research communications | 2022

von Mirza, M. | Lindahl, G. | Mahner, S. | +17

8

DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers

enthalten in: Journal of experimental & clinical cancer research : CR | 2022

von Gull, N. | Jones, M. | Peng, P. | +18

9

DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers

enthalten in: Journal of experimental & clinical cancer research | 2022

von Gull, N. | Jones, M. | Peng, P. | +18

10

DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers

enthalten in: Journal of experimental & clinical cancer research | 2022

von Gull, N. | Jones, M. | Peng, P. | +18